• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Anthem, Inc. Names Dr. Shantanu Agrawal Chief Health Officer

    12/16/20 5:00:00 PM ET
    $ANTM
    Medical Specialities
    Health Care
    Get the next $ANTM alert in real time by email

    INDIANAPOLIS--(BUSINESS WIRE)--Anthem, Inc. (NYSE: ANTM) announced today Dr. Shantanu Agrawal has been named Chief Health Officer, effective January 25, 2020. Dr. Agrawal will oversee Anthem’s enterprise health strategy, to include medical policy and clinical quality, as well as the company’s industry-leading work to address the social drivers of health. He will also lead Anthem’s community health strategy and the Anthem Foundation. He will report directly to Gail K. Boudreaux, President and Chief Executive Officer, Anthem.

    “Dr. Agrawal’s extensive experience in both the public and private sectors will further accelerate Anthem’s efforts around ‘whole person care’ in order to improve outcomes and reduce costs for all those we serve,” said Gail K. Boudreaux. “He is a transformative thought leader, and I am excited to welcome him to Anthem.”

    Dr. Agrawal most recently served as President and Chief Executive Officer of the National Quality Forum (NQF), a non-profit organization dedicated to working with members of the healthcare community to drive measurable health improvements. He is also the former Deputy Administrator for the Centers for Medicare & Medicaid Services (CMS), where he led an effort to improve the physician experience with Medicare and was also was one of the main architects of CMS’s strategy to address the national opioid epidemic. Dr. Agrawal also served as Director of the Center for Program Integrity (CPI), where he was instrumental in launching new initiatives in data transparency and analytics, utilization management and payment models.

    Dr. Agrawal serves on the board of the Grameen Foundation and the Presidential Advisory Council of Brown University’s School of Public Health. He is also Adjunct Senior Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania and Associate Clinical Professor of Emergency Medicine at the George Washington University School of Medicine.

    Dr. Agrawal completed his undergraduate education at Brown University, medical education at Weill Medical College of Cornell University, and clinical training in Emergency Medicine at the Hospital of the University of Pennsylvania. He earned his master’s degree in Social and Political Sciences from Cambridge University.

    About Anthem, Inc.

    Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 107 million people, including approximately 43 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner. For more information, please visit www.antheminc.com or follow @AnthemInc on Twitter.

    Get the next $ANTM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANTM

    DatePrice TargetRatingAnalyst
    6/22/2022$607.00 → $533.00Overweight → Equal-Weight
    Morgan Stanley
    6/17/2022$550.00Buy
    Loop Capital
    5/27/2022$577.00 → $596.00Outperform
    Bernstein
    2/7/2022$475.00 → $500.00Buy
    Argus Research
    1/28/2022$561.00 → $518.00Overweight
    Morgan Stanley
    1/27/2022$430.00 → $465.00Market Perform
    SVB Leerink
    12/20/2021$450.00 → $510.00Neutral → Buy
    Mizuho
    12/17/2021$486.00 → $561.00Overweight
    Morgan Stanley
    More analyst ratings

    $ANTM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Todt Blair Williams was granted 3,983 shares, increasing direct ownership by 93% to 8,283 units

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    1/5/23 5:03:57 PM ET
    $ANTM
    Medical Specialities
    Health Care

    SEC Form 4: Norwood Felicia F covered exercise/tax liability with 1,754 shares, decreasing direct ownership by 6% to 26,684 units

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    1/4/23 4:50:33 PM ET
    $ANTM
    Medical Specialities
    Health Care

    SEC Form 4: Todt Blair Williams covered exercise/tax liability with 117 shares, decreasing direct ownership by 3% to 4,300 units

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    12/5/22 4:53:39 PM ET
    $ANTM
    Medical Specialities
    Health Care

    $ANTM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Anthem Announces Subsidiary Brands Under Elevance Health

    Changes reflect the company's continued evolution to support whole health As Anthem, Inc. (ANTM) moves closer to rebranding to Elevance Health, Inc. later this month, the company today announced the launch of healthcare services brand Carelon and health plan brand Wellpoint to join the company's family of brands that includes Anthem Blue Cross and Blue Shield. The move will optimize and streamline the company's brand portfolio, reduce complexities, and further underscore its evolution to deliver solutions beyond traditional health insurance, simplify the healthcare experience, and advance health beyond healthcare. "An important part of being a lifetime, trusted health partner is grounded

    6/15/22 10:00:00 AM ET
    $ANTM
    Medical Specialities
    Health Care

    Anthem, Inc. Aims to Enhance Maternal Health with New Digital-First Solution

    Anthem partners with Happify Health to bring innovative digital health services to areas of women's health including pregnancy, menopause, and more Anthem, Inc. (NYSE:ANTM), a leading health company dedicated to improving lives and communities, will add to its ongoing support of the whole health of women with the addition of a new a digital-first solution in select markets. This program, a collaboration between Anthem – soon to be Elevance Health on June 28 – and Happify Health, bridges the gap between the unique physical and mental health concerns women face. It is part of Anthem's early and consistent support of women throughout the entirety of their maternal health journey with solution

    6/7/22 7:55:00 AM ET
    $ANTM
    Medical Specialities
    Health Care

    Anthem Announces Appearance at Upcoming Conference

    Anthem, Inc. (NYSE:ANTM) announced today that senior management is scheduled to present at the 38th Annual Bernstein Strategic Decisions Conference in New York City on June 3, at 8:00 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a webcast of the presentation by visiting www.antheminc.com and selecting the "Investors" link. Following the presentation, a webcast replay will be available for two weeks. To listen to the live webcast, please visit Anthem's website at least 15 minutes early to download and install any necessary audio software. Individuals who listen to the presentations will be presumed to have read Anthem's most recent filings with the SEC,

    5/26/22 4:05:00 PM ET
    $ANTM
    Medical Specialities
    Health Care

    $ANTM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $ANTM
    SEC Filings

    View All

    Anthem downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Anthem from Overweight to Equal-Weight and set a new price target of $533.00 from $607.00 previously

    6/22/22 7:17:32 AM ET
    $ANTM
    Medical Specialities
    Health Care

    Loop Capital initiated coverage on Anthem with a new price target

    Loop Capital initiated coverage of Anthem with a rating of Buy and set a new price target of $550.00

    6/17/22 7:14:30 AM ET
    $ANTM
    Medical Specialities
    Health Care

    Bernstein resumed coverage on Anthem with a new price target

    Bernstein resumed coverage of Anthem with a rating of Outperform and set a new price target of $596.00 from $577.00 previously

    5/27/22 7:11:36 AM ET
    $ANTM
    Medical Specialities
    Health Care

    Anthem Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Elevance Health, Inc. (0001156039) (Filer)

    11/4/22 4:16:09 PM ET
    $ANTM
    Medical Specialities
    Health Care

    SEC Form 424B3 filed by Anthem Inc.

    424B3 - Elevance Health, Inc. (0001156039) (Filer)

    10/27/22 4:22:42 PM ET
    $ANTM
    Medical Specialities
    Health Care

    SEC Form FWP filed by Anthem Inc.

    FWP - Elevance Health, Inc. (0001156039) (Subject)

    10/26/22 5:22:59 PM ET
    $ANTM
    Medical Specialities
    Health Care

    $ANTM
    Leadership Updates

    Live Leadership Updates

    View All

    Treace Medical Concepts Appoints New Directors

    PONTE VEDRA, Fla., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions), today announced the appointment of Betsy Hanna and Deepti Jain to its Board of Directors effective October 1, 2021. "With decades of combined experience in healthcare leadership, Ms. Hanna and Ms. Jain strengthen the expertise of our Company's Board of Directors," said James T. Treace, the Company's Chairman of the Board. "Our executive leadership and board are pleased to add two individuals with their stellar reputa

    10/4/21 8:00:00 AM ET
    $ANTM
    $TCMD
    $TMCI
    Medical Specialities
    Health Care
    Medical/Dental Instruments

    David P. Abney, Gail K. Boudreaux Named to Target Corporation's Board of Directors

    MINNEAPOLIS, Aug. 11, 2021 /PRNewswire/ -- Target Corporation (NYSE:TGT) announced today its board of directors elected David P. Abney, former chairman of the board and chief executive officer of United Parcel Service, Inc., and Gail K. Boudreaux, president and chief executive officer of Anthem, Inc., as directors. Mr. Abney's appointment is effective immediately and Ms. Boudreaux's appointment becomes effective September 23, 2021. Mr. Abney, 65, held a series of escalating leadership roles at UPS over his more than 40-year career. He was named CEO in September 2014 and chairman and CEO in February 2016, a role he held until announcing his retirement in June 2020. He remained executive chair

    8/11/21 4:05:00 PM ET
    $ANTM
    $TGT
    Medical Specialities
    Health Care
    Department/Specialty Retail Stores
    Consumer Discretionary

    Dante Labs Announces Appointment of Healthcare Veteran and GRAIL SVP Mark Morgan to Board Of Directors to Support Genomic and Precision Medicine Scaling in the United States

    CAMBRIDGE, United Kingdom, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, announced today the appointment of Mark Morgan as a board member. Mark is the SVP of Market Access for GRAIL, which has developed a highly innovative multi-cancer, early detection blood test. "We are excited to welcome Mark Morgan to the Dante Labs Board," said Dante Labs CEO Andrea Riposati, "Mark is a rockstar in healthcare. His deep experience with health plans, coupled with market access expertise in both biopharma and diagnostics will be invaluable to Dante Labs as we continue to build on our global success and expansion in the United States." Mr. Morgan state

    8/9/21 7:39:23 AM ET
    $AMGN
    $ANTM
    $ILMN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Medical Specialities

    $ANTM
    Financials

    Live finance-specific insights

    View All

    Anthem, Inc. Completes Acquisition of Integra Managed Care

    Anthem, Inc. (NYSE:ANTM) today announced the completion of its acquisition of Integra Managed Care, a Managed Long-Term Care Plan in New York that helps adults with long term care needs and disabilities live safely and independently in their own home. "We're pleased to complete this acquisition and work alongside our new colleagues as we continue to grow our Medicaid business and enhance the healthcare experience for all of our members," said Felicia Norwood, Executive Vice President of Anthem's Government Business Division. "Anthem and Integra's shared commitment to deliver high quality, comprehensive whole-health care across communities throughout New York ensures that our members will c

    5/5/22 7:48:00 AM ET
    $ANTM
    Medical Specialities
    Health Care

    Anthem Reports First Quarter 2022 Results, Reflecting Strong Momentum Across All Divisions

    First quarter GAAP net income was $7.39 per share, including net negative adjustment items of $0.86 per share. Adjusted net income was $8.25* per share. Operating revenue grew by 18.0% over the prior year quarter to $37.9 billion. Operating gain grew by 13.2% over the prior year quarter to $2.4 billion. Medical enrollment increased by 3.3 million members year-over-year and 1.4 million members sequentially to 46.8 million members. Second quarter 2022 dividend of $1.28 per share declared to shareholders. Anthem, Inc. (NYSE:ANTM) reported first quarter 2022 results reflecting strong financial performance, including double-digit top and bottom line growth. "Our strong momentum a

    4/20/22 6:00:00 AM ET
    $ANTM
    Medical Specialities
    Health Care

    Anthem to Hold Conference Call and Webcast to Discuss First Quarter Results on April 20, 2022

    Anthem, Inc. (NYSE:ANTM) will release first quarter 2022 financial results on April 20, 2022, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 (Domestic) 800-813-5525 (Domestic Replay) 312-470-0178 (International) 203-369-3346 (International Replay) The access code for the call is 3972058. There is no access code for the replay. The replay will be available from 11:30 a.m. EDT on April 20, 2022 until the end of the day on May 20, 2022. The cal

    4/6/22 4:05:00 PM ET
    $ANTM
    Medical Specialities
    Health Care

    $ANTM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Anthem Inc. (Amendment)

    SC 13G/A - Anthem, Inc. (0001156039) (Subject)

    2/9/22 3:24:47 PM ET
    $ANTM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed

    SC 13G/A - Anthem, Inc. (0001156039) (Subject)

    2/10/21 10:30:29 AM ET
    $ANTM
    Medical Specialities
    Health Care